Palantir Technologies' (PLTR) Q1 results were "equally impressive" as its Q4 performance, driven by strong growth in US commercial and government segments, Morgan Stanley said in a note Tuesday.
The results were seen as particularly strong given broader economic uncertainty and prior concerns about whether large government and commercial deals would close.
Total revenue rose 39% year-over-year to $883.9 million, marking the company's seventh straight quarter of accelerating growth. US commercial revenue climbed 70% from a year earlier and 19% sequentially to $255 million, driven by momentum around the company's artificial intelligence platform offering.
Government strength was also notable, with international government revenue accelerating to 46% growth, helped by expanded partnerships with the UK's NHS and NATO. However, the international commercial segment remained a weak spot, declining 5% year-over-year after showing 3% growth in Q4, according to the note.
The firm highlighted margin outperformance, with adjusted operating margin at 44%, 200 basis points ahead of consensus. Free cash flow also exceeded expectations at $370 million, after adjusting for $66 million in payroll taxes related to stock-based compensation.
Despite Palantir's continued momentum and status as a top AI beneficiary in software, Morgan Stanley maintained an equal-weight rating and raised its price target on the company to $98 from $90.
Shares of Palantir Technologies were down nearly 12% in recent trading.
Price: 108.99, Change: -14.78, Percent Change: -11.94
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.